Genpact Limited $G Stake Lessened by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management B.V. cut its Genpact stake by 44% in the third quarter, selling 52,090 shares and retaining 66,339 shares valued at approximately $2.16 million.
• Institutional investors own 96.03% of Genpact’s outstanding shares, while several funds—including WINTON GROUP, Engineers Gate, Tidal Investments, and CX Institutional—expanded their positions.
• Analysts maintain a consensus “Hold” rating with an average price target of $39.67. Genpact recently declared a quarterly dividend of $0.1875 per share, equivalent to a 1.8% yield.

Robeco Institutional Asset Management B.V. lowered its position in Genpact Limited (NYSE:G - Free Report) by 44.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 66,339 shares of the business services provider's stock after selling 52,090 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in Genpact were worth $2,158,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of G. WINTON GROUP Ltd lifted its stake in shares of Genpact by 178.8% in the 2nd quarter. WINTON GROUP Ltd now owns 48,666 shares of the business services provider's stock worth $1,338,000 after acquiring an additional 31,213 shares during the period. Engineers Gate Manager LP boosted its stake in shares of Genpact by 42.9% during the 2nd quarter. Engineers Gate Manager LP now owns 224,729 shares of the business services provider's stock worth $6,180,000 after acquiring an additional 67,482 shares in the last quarter. Tidal Investments LLC boosted its stake in shares of Genpact by 135.5% during the 2nd quarter. Tidal Investments LLC now owns 57,011 shares of the business services provider's stock worth $1,568,000 after acquiring an additional 32,805 shares in the last quarter. CX Institutional grew its holdings in shares of Genpact by 102.7% in the 3rd quarter. CX Institutional now owns 361,074 shares of the business services provider's stock worth $11,746,000 after acquiring an additional 182,960 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Genpact in the 2nd quarter worth approximately $1,452,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, SVP Anil Nanduru sold 6,191 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total transaction of $229,252.73. Following the sale, the senior vice president owned 70,253 shares of the company's stock, valued at $2,601,468.59. This trade represents a 8.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.58% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on G shares. Deutsche Bank Aktiengesellschaft set a $31.00 price objective on Genpact in a research note on Friday, July 10th. Susquehanna boosted their target price on Genpact from $37.00 to $40.00 and gave the stock a "neutral" rating in a research report on Thursday. Robert W. Baird lowered their target price on Genpact from $45.00 to $38.00 and set a "neutral" rating on the stock in a report on Tuesday, July 7th. Weiss Ratings upgraded Genpact from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday, October 14th. Finally, JPMorgan Chase & Co. raised their price target on Genpact from $40.00 to $45.00 and gave the company a "neutral" rating in a research report on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $39.67.

Genpact Trading Up 0.1%

Shares of G opened at $40.86 on Monday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.00 and a quick ratio of 2.00. Genpact Limited has a 1-year low of $26.85 and a 1-year high of $48.64. The stock has a market cap of $6.83 billion, a price-to-earnings ratio of 12.12, a price-to-earnings-growth ratio of 1.09 and a beta of 0.57. The firm has a 50 day simple moving average of $35.80 and a 200-day simple moving average of $33.56.

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Tuesday, June 30th. The business services provider reported $1.00 earnings per share (EPS) for the quarter. The firm had revenue of $1.34 billion for the quarter. Genpact had a return on equity of 23.34% and a net margin of 11.04%. Equities analysts forecast that Genpact Limited will post 3.66 EPS for the current fiscal year.

Genpact Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 23rd. Stockholders of record on Thursday, December 10th will be given a $0.1875 dividend. This represents a $0.75 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Thursday, December 10th. Genpact's dividend payout ratio is currently 22.26%.

Genpact Profile

Genpact NYSE: G is a global professional services and business process management company that helps organizations improve operations through digital transformation, data and analytics, artificial intelligence, and industry-specific expertise. The company combines technology with operational services to support clients across core business functions.

Its offerings include finance and accounting, procurement, supply chain management, customer experience, risk and compliance, insurance operations, and banking and capital markets services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.